UK Oncology Clinical Trials Market Analysis

UK Oncology Clinical Trials Market Analysis

$ 3999

UK oncology clinical trials market is projected to grow from $328.9 Mn in 2022 to $433.1 Mn by 2030, registering a CAGR of 3.50% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in the UK and efforts to promote research, collaboration, and innovation. The market is segmented by phase, study design, and indication. Some of the major players include Novartis AG, AstraZeneca & Astex Pharmaceuticals.

ID: IN10GBCT006 CATEGORY: Clinical Trials GEOGRAPHY: UK AUTHOR: Vidhi Upadhyay

Buy Now

UK Oncology Clinical Trials Market Executive Summary

UK oncology clinical trials market is projected to grow from $328.9 Mn in 2022 to $433.1 Mn by 2030, registering a CAGR of 3.50% during the forecast period of 2022-30. Healthcare spending in the United Kingdom will account for 11.9% of the GDP by 2021. In England, 1,390,483 people participated in clinical research in 2020/2021, about twice the number that participated in 2019/2020. In 2020, the UK contributed for 3.6% of worldwide clinical trial activity. Every year, over 167,000 people die from cancer in the UK, which equates to almost 460 fatalities every day. Lung, bowel, breast, and prostate cancer account for about half of all cancer fatalities in the UK.

The United Kingdom has also been a pioneer in the development of precision medicine cancer treatment techniques, which entail analyzing genetic and other molecular data to personalize therapies for specific patients. The 100,000 Genomes Project, which sought to sequence the genomes of 100,000 persons suffering from cancer or uncommon disorders, was an important endeavor in this field, giving crucial data for research and therapeutic trials.

In terms of individual clinical trials, the UK presently has a diverse set of studies active, encompassing a broad variety of cancer types and treatment options. The CRUK-funded TRACERx project, for example, is looking at the genetic development of lung cancer and how it influences therapy response, whilst the NIHR-funded RECOVERY trial is looking into the efficacy of different COVID-19 therapies in cancer patients. Generally, the United Kingdom has a robust and active cancer clinical trial environment, with continuing efforts to foster cooperation and innovation, as well as to ensure that patients have access to the most recent and effective treatments.

UK oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

The United Kingdom has also been a pioneer in the development of precision medicine cancer treatment techniques, which entail analyzing genetic and other molecular data to personalize therapies for specific patients. The 100,000 Genomes Project, which sought to sequence the genomes of 100,000 persons suffering from cancer or uncommon disorders, was an important endeavor in this field, giving crucial data for research and therapeutic trials.

The UK government has aggressively promoted cancer research and development, providing funding and facilities to enable clinical studies. The government's Life Sciences Industrial Plan included a goal to increase the number of clinical trials in the UK by 2021. In the United Kingdom, there is a long history of partnership between research universities and the pharmaceutical business, which will aid in driving innovation and accelerating the development of novel therapies.

Market Restraints

According to research released by the Association of British Pharmaceutical Industry, the number of industry-backed clinical trials launched in the UK each year declined by 41% between 2017 and 2021. According to the ABPI, pharma firms are increasingly locating their trials in other countries such as Spain and Australia, and this has already impacted the UK's global position for phase III industry clinical trials, which has dropped from fourth place in 2017 to tenth place in 2021.

Moreover, clinical trial regulations may be complicated and time-consuming, with tight requirements governing patient safety and data security. This may be an impediment to conducting clinical trials, especially for smaller businesses or academic institutions. Clinical studies are expensive to carry out, and funds may be difficult to come by. This may reduce the number of studies conducted, especially for uncommon cancers or therapies that are less financially feasible. Patient recruitment for clinical trials may be challenging, especially for studies requiring a high number of participants or including complicated treatment regimens.

Competitive Landscape

Key Players

  • Novartis AG
  • AstraZeneca PLC
  • Merck & Co Inc.
  • FHoffmann-La Roche Ltd
  • Pfizer Inc.
  • Abcam Plc (GBR)
  • Astex Pharmaceuticals (GBR)
  • CellCentric (GBR)
  • Sareum (GBR)

Notable Insights

  1. January 2023, The UK government launched a collaboration with the German business BioNTech on Friday to explore possible cancer and other illness vaccines
  2. December 2022, In the first phase III study, a new targeted medicine (Capivasertib) showed effectiveness against breast cancer. Capivasertib is a first-in-class medication that inhibits the activity of the cancer-causing protein molecule AKT. It was discovered by AstraZeneca during a drug discovery research program at The Institute of Cancer Research in London in conjunction with Astex Pharmaceuticals.

Healthcare Policies and Regulatory Landscape

The Medicines and Healthcare products Regulatory Agency (MHRA) is in charge of ensuring that clinical trials are done in a safe and ethical way in the United Kingdom.

The National Cancer Research Institute (NCRI), Cancer Research UK (CRUK), and the National Institute for Health Research are all active in cancer clinical trials in the United Kingdom (NIHR). These organizations offer clinical trial financing, assistance, and infrastructure, as well as organizing research activities and encouraging cooperation between researchers and healthcare professionals.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 February 2024
Updated by: Vidhi Upadhyay

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter